KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization Amortization Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Novartis Ag (NVS) Sales of Property, Plant and Equipment (2017 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Sales of Property, Plant and Equipment (Qtr)
1	Novartis Ag	107,124,802.25 Bn	107,124,802.25 Bn	-	5.00 Mn
2	Eli Lilly	969.00 Bn	963.72 Bn	16.22 Bn	-
3	Johnson & Johnson	539.46 Bn	517.41 Bn	15.96 Bn	29.00 Mn
4	AbbVie	376.92 Bn	367.57 Bn	10.78 Bn	-
5	Merck	285.00 Bn	279.35 Bn	12.09 Bn	-
6	Amgen	177.58 Bn	165.55 Bn	5.87 Bn	-
7	Gilead Sciences	163.22 Bn	155.50 Bn	5.52 Bn	-
8	Pfizer	145.86 Bn	133.09 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	111.90 Bn	101.44 Bn	8.07 Bn	-
10	Gsk	88.34 Bn	83.66 Bn	-	-

Historic Data

Download Data 🔒

Date	Value
Mar 31, 2026	5.00 Mn
Mar 31, 2026	5.00 Mn
Dec 31, 2025	1.00 Mn
Dec 31, 2025	1.00 Mn
Sep 30, 2025	1.00 Mn
Sep 30, 2025	1.00 Mn
Jun 30, 2025	1.00 Mn
Jun 30, 2025	1.00 Mn
Mar 31, 2025	10.00 Mn
Mar 31, 2025	10.00 Mn
Dec 31, 2024	47.00 Mn
Dec 31, 2024	47.00 Mn
Sep 30, 2024	1.00 Mn
Sep 30, 2024	1.00 Mn
Jun 30, 2024	37.00 Mn
Jun 30, 2024	37.00 Mn
Mar 31, 2024	1.00 Mn
Mar 31, 2024	1.00 Mn
Dec 31, 2023	164.00 Mn
Dec 31, 2023	164.00 Mn
Sep 30, 2023	51.00 Mn
Sep 30, 2023	51.00 Mn
Jun 30, 2023	4.00 Mn
Jun 30, 2023	4.00 Mn
Mar 31, 2023	18.00 Mn
Mar 31, 2023	18.00 Mn
Dec 31, 2022	102.00 Mn
Dec 31, 2022	102.00 Mn
Sep 30, 2022	20.00 Mn
Sep 30, 2022	20.00 Mn
Jun 30, 2022	13.00 Mn
Jun 30, 2022	13.00 Mn
Mar 31, 2022	33.00 Mn
Mar 31, 2022	33.00 Mn
Dec 31, 2021	74.00 Mn
Dec 31, 2021	74.00 Mn
Sep 30, 2021	81.00 Mn
Sep 30, 2021	81.00 Mn
Jun 30, 2021	19.00 Mn
Jun 30, 2021	19.00 Mn
Mar 31, 2021	66.00 Mn
Mar 31, 2021	66.00 Mn
Dec 31, 2020	82.00 Mn
Dec 31, 2020	82.00 Mn
Sep 30, 2020	2.00 Mn
Sep 30, 2020	2.00 Mn
Jun 30, 2020	1.00 Mn
Jun 30, 2020	1.00 Mn
Mar 31, 2020	3.00 Mn
Mar 31, 2020	3.00 Mn
Dec 31, 2019	48.00 Mn
Dec 31, 2019	48.00 Mn
Sep 30, 2019	-3.00 Mn
Sep 30, 2019	-3.00 Mn
Jun 30, 2019	648.00 Mn
Jun 30, 2019	648.00 Mn
Mar 31, 2019	164.00 Mn
Mar 31, 2019	164.00 Mn
Dec 31, 2018	47.00 Mn
Dec 31, 2018	47.00 Mn
Sep 30, 2018	4.00 Mn
Sep 30, 2018	4.00 Mn
Jun 30, 2018	6.00 Mn
Jun 30, 2018	6.00 Mn
Mar 31, 2018	45.00 Mn
Mar 31, 2018	45.00 Mn
Dec 31, 2017	30.00 Mn
Dec 31, 2017	30.00 Mn
Sep 30, 2017	46.00 Mn
Sep 30, 2017	46.00 Mn
Jun 30, 2017	7.00 Mn
Jun 30, 2017	7.00 Mn
Mar 31, 2017	9.00 Mn
Mar 31, 2017	9.00 Mn